Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Deloitte
Daiichi Sankyo
Medtronic
Fuji
AstraZeneca

Generated: August 24, 2019

DrugPatentWatch Database Preview

Patent: 8,883,775

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,883,775
Title:Treatment of hyperproliferative diseases with vinca alkaloid N-oxide analogs
Abstract: The present invention relates to vinca alkaloid and analog N-oxides having activity for treating hyperproliferative disorders. Further, the invention relates to pharmaceutical compositions and methods of using vinca alkaloid and analog N-oxides, alone or in combination with one or more other active agents or treatments, to treat hyperproliferative disorders.
Inventor(s): Curd; John G. (Hillsborough, CA), Keana; John F. W. (Eugene, OR), Lalani; Alshad S. (Terrytown, NY), Westberg; Paul B. (San Mateo, CA), Goodwin; Bradford (San Mateo, CA), Henner; W. David (Tucson, AZ)
Assignee: Cascade Prodrug Inc. (Eugene, OR)
Application Number:13/280,974
Patent Claims:see list of patent claims

Details for Patent 8,883,775

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26 ➤ Sign Up Cascade Prodrug Inc. (Eugene, OR) 2036-04-30 RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26 ➤ Sign Up Cascade Prodrug Inc. (Eugene, OR) 2036-04-30 RX search
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18 ➤ Sign Up Cascade Prodrug Inc. (Eugene, OR) 2036-04-30 RX Orphan search
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31 ➤ Sign Up Cascade Prodrug Inc. (Eugene, OR) 2036-04-30 RX Orphan search
Spectrum Pharms ZEVALIN ibritumomab tiuxetan INJECTABLE; INJECTION 125019 001 2002-02-19 ➤ Sign Up Cascade Prodrug Inc. (Eugene, OR) 2036-04-30 RX Orphan search
Amgen ARANESP darbepoetin alfa VIAL; SUBCUTANEOUS 103951 010 2001-09-17 ➤ Sign Up Cascade Prodrug Inc. (Eugene, OR) 2036-04-30 RX search
Amgen ARANESP darbepoetin alfa VIAL; SUBCUTANEOUS 103951 009 2001-09-17 ➤ Sign Up Cascade Prodrug Inc. (Eugene, OR) 2036-04-30 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 8,883,775

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2007098091 Aug 28, 2008
World Intellectual Property Organization (WIPO) 2007098091 Aug 30, 2007
United States of America 2008305075 Dec 11, 2008
United States of America 2012107230 May 03, 2012
United States of America 8048872 Nov 01, 2011
Japan 2009527480 Jul 30, 2009
Japan 5596924 Sep 24, 2014
>Country >Patent Number >Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Farmers Insurance
UBS
Mallinckrodt
Harvard Business School
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.